Tagged with EY

Turkey In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent. Treve provided insights into the main opportunities and challenges of the Turkish market, Roche’s unrivalled commitment to making a difference…

Turkey Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging population. In addition, as the newly appointed Chairman of the Board of Directors of the Association of Research-Based Pharmaceutical Companies…

UK Karen Osborn, CEO of the International Glaucoma Association, explains the role of the charity, detailing its threefold purpose of funding research, raising awareness and helping patients live with the disease. She speaks about possible care pathways of the future and international collaboration on research.   We also collaborate on workshops…

Turkey Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of Health in the country, in addition to offering a deep analysis of his assessment of the cardiology landscape, and why…

Turkey Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in her second general manager position, sets out her priorities, comments on the marriage of Turkish and Japanese work practices, and…

Turkey Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the next steps ahead to further improve access to innovation in Turkey and ensure the country continues to be seen as…

Turkey Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the healthcare sector. However, he has high hopes that the country will continue to prioritize oncology as a key therapeutic area…

Turkey Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s background, with their ground-breaking biosimilars as the leaders in the area of oncology with 85 products approved in Turkey, in…

Turkey Gilles Renacco, the recently appointed general manager of Servier Turkey, provides insights into the successful localization process pioneered by Servier in the country, where 98 percent of the company’s products are nowadays locally manufactured. He also highlights the strategic importance of the country for the Servier Group, his key priorities…

Turkey Christopher Gaunt, chairman of the British Chamber of Commerce in Turkey, analyzes the relationship between the two countries and the ongoing development of their relationship, in addition to how UK companies can bring their experience and knowledge about public-private partnerships to the country and further strengthen  economic and bilateral trade.…

Turkey Bahadir Kaleagasi, secretary general of the Turkish Industry & Business Association (TÜSIAD) discusses the strengths of the country as Europe’s gateway to Asia in addition to the strong investment landscape the country still has. He comments that if all the key stakeholders add a “drop to the ocean of progress”…

UK Philip Lews Williams, managing director of the UK affiliate of French ophthalmology specialist Théa, describes the evolution of the company’s engagement in the UK and his strategy for taking on the big players in eyecare. Laboratoires Théa entered the UK for the first time back in 2007 via a joint…